Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

February 02, 2024 15:29 (London Time)

AnaptysBio

Youtube Subscribe

...

Sector: Biotechnology
Ticker: ANAB
Sentiment: 0.5574
MarketCap: 644,448,066.0
High: 24.15 Low: 23.89

Open: 23.94 Close: 23.99 Change: 0.05

13 risks of investing in AnaptysBio found by an AI after reading the whole internet.

Are looking for the most relevant information about AnaptysBio? Investor spend a lot of time searching for information to make investment decisions in AnaptysBio. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AnaptysBio are: AnaptysBio, Inc, CEO, factory, order, December, line, and the most common words in the summary are: view, inc, profile, anaptysbio, state, united, co, . One of the sentences in the summary was: AnaptysBio Inc. Other searches related to this term that the AI found were: stockmarketlive, …

Concept Map

...

Semantic Network

...

Stock Summary

AnaptysBio, Inc. focuses in delivering immunology therapeutics. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 trial for the.

Today's Summary

AnaptysBio Inc. factory orders up 0.2% in December, in line with consensus 10:00a Uniswap leads gains as large cryptocurrencies start mixed to be replaced. AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares. CEO reported an insider sale according to a recent SEC filing.

Today's News

AnaptysBio Inc. factory orders up 0.2% in December, in line with consensus 10:00a Uniswap leads gains as large cryptocurrencies start mixed to be replaced. AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares. CEO reported an insider sale according to a recent SEC filing.

Stock Profile

"AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 trial for the treatment of generalized pustular psoriasis; Rosnilimab, an anti-PD-1 agonist antibody program designed to suppress T-cell driven inflammatory diseases by augmenting signaling through PD-1 or targeted depletion of PD-1+ T cells; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California."

Keywords

How much time have you spent trying to decide whether investing in AnaptysBio? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AnaptysBio are: AnaptysBio, Inc, CEO, factory, order, December, line, and the most common words in the summary are: view, inc, profile, anaptysbio, state, united, co, . One of the sentences in the summary was: AnaptysBio Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #view #inc #profile #anaptysbio #state #united #co.

Read more →

Related Results

...
February 02, 2024 15:29 (London Time)

AnaptysBio

AnaptysBio Inc. factory orders up 0.2% in December, in line with consensus 10:00a Uniswap leads gains as large cryptocurrencies start mixed to be re…
Sector: Biotechnology
Ticker: ANAB
Sentiment: 0.5574
MarketCap: 644,448,066.0
High: 24.15 Low: 23.89

Open: 23.94 Close: 23.99 Change: 0.05

Read more →
...
May 26, 2023 22:24 (London Time)

AnaptysBio

Consensus Just Cut Its AnaptysBio, Inc. (NASDAQ:ANAB) Estimates For 2023. Revenues to the end of 2023 expected to display 12% growth on an annualise…
Sector: Biotechnology
Ticker: ANAB
Sentiment: 0.6676
MarketCap: 500,840,871.0
High: 18.72 Low: 18.32

Open: 18.59 Close: 18.65 Change: 0.06

Read more →
...
September 01, 2023 18:46 (London Time)

AnaptysBio

The leading companies working in the Acne Vulgaris market include Novan Inc., Bausch Health Americas, Inc., AOBiome LLC, Ascletis Pharmaceuticals, A…
Sector: Biotechnology
Ticker: ANAB
Sentiment: 0.0
MarketCap: 522,416,975.0
High: 19.94 Low: 19.45

Open: 19.74 Close: 19.74 Change: 0.0

Read more →
...
May 18, 2023 11:03 (London Time)

AnaptysBio

Guggenheim increased their price target on shares of AnaptysBio from $44.00 to $45.00 in a report on Friday, May 12th. AnaptyysBio has a consensus r…
Sector: Biotechnology
Ticker: ANAB
Sentiment: 0.5106
MarketCap: 500,840,871.0
High: 19.22 Low: 18.03

Open: 18.68 Close: 19.05 Change: 0.37

Read more →